Needle-Free Transdermal Delivery Startup Prometheon Pharma Opens Platform To Promote Industry Partnerships
GAINESVILLE, Fla.--(BUSINESS WIRE)--As the biotech industry and investors converge on San Franscisco for the JP Morgan Healthcare Conference, University of Florida spinoff Prometheon Pharma announced plans to open its needle-free transdermal patch technology platform to promote industry partnerships.
“We created a simple, de-risked, and success-based process that allows for quick decisions and minimal commitment. This allows partners to respond to changing markets or strategic plans,” said Dr. Stephen Hsu, CEO of Prometheon Pharma and inventor of its technology.
Help employers find you! Check out all the jobs and post your resume.
“We created a simple, de-risked, and success-based process that allows for quick decisions and minimal commitment. This allows partners to respond to changing markets or strategic plans,” said Dr. Stephen Hsu, CEO of Prometheon Pharma and inventor of its technology.
Help employers find you! Check out all the jobs and post your resume.